Quantification of conjunctival vascular reaction by digital imaging

被引:24
作者
Horak, F
Berger, U
Menapace, R
Schuster, N
机构
[1] UNIV VIENNA, EYE CLIN B, VIENNA, AUSTRIA
[2] OLYMPUS OPT CO EUROPE, HAMBURG, GERMANY
关键词
conjunctival provocation test; conjunctival allergic inflammation; vascular reaction; video equipment; red density;
D O I
10.1016/S0091-6749(96)70081-7
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: No objective evaluation of the conjunctival provocation test (CPT) was possible until now. Objective: The aim of this study was to develop a tool that would enable us to monitor conjunctival allergic inflammation by objective measurements. Methods: Twenty-four patients allergic to grass pollen were challenged by a CPT with grass pollen and genuine grass pollen in the ''Vienna Challenge Chamber.'' Patients were randomized to treatment with placebo or topical application of an H1-receptor antagonist (azelastine). Vascular reaction of the conjunctiva was repeatedly monitored by special video equipment. The signal was sent to a digital frame grabber, and digital image analysis was done with the aid of the WCUE-3 program (Olympus Optical Co., Hamburg, Germany). Results: The CPT led to an immediate increase of the red density. This extension was linear within the first 15 minutes. During the long-term challenge, the increasing vascular effect lasted 2 hours. During active treatment a consistent reaction pattern was obvious; however, the corresponding levels were statistically lower (p = 0.022). Conclusion: The calculation of red density of the conjunctiva by digital analysis proved to be a sensitive tool for measuring the conjunctival allergic reaction. It is possible to overcome the insufficient subjective evaluation of the CPT by objective measurements of the vascular reaction.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 15 条
[1]   GUIDELINES FOR BRONCHOPROVOCATION ON THE INVESTIGATION OF OCCUPATIONAL ASTHMA - REPORT OF THE SUBCOMMITTEE-ON-BRONCHOPROVOCATION-FOR-OCCUPATIONAL-ASTHMA [J].
CARTIER, A ;
BERNSTEIN, IL ;
BURGE, PS ;
COHN, JR ;
FABBRI, LM ;
HARGREAVE, FE ;
MALO, JL ;
MCKAY, RT ;
SALVAGGIO, JE .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (05) :823-829
[2]   DEFLAZACORT PROTECTS AGAINST LATE-PHASE BUT NOT EARLY-PHASE REACTIONS INDUCED BY THE ALLERGEN-SPECIFIC CONJUNCTIVAL PROVOCATION TEST [J].
CIPRANDI, G ;
BUSCAGLIA, S ;
PESCE, GP ;
IUDICE, A ;
BAGNASCO, M ;
CANONICA, GW .
ALLERGY, 1993, 48 (06) :421-430
[3]   PROTECTIVE EFFECT OF LORATADINE ON SPECIFIC CONJUNCTIVAL PROVOCATION TEST [J].
CIPRANDI, G ;
BUSCAGLIA, S ;
PESCE, GP ;
MARCHESI, E ;
CANONICA, GW .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1991, 96 (04) :344-347
[4]   PROTECTIVE EFFECT OF DIFFERENT DOSES OF TERFENADINE ON THE CONJUNCTIVAL PROVOCATION TEST [J].
CIPRANDI, G ;
BUSCAGLIA, S ;
IUDICE, A ;
CANONICA, GW .
ALLERGY, 1992, 47 (04) :309-312
[5]   POSITION PAPER - ALLERGEN STANDARDIZATION AND SKIN-TESTS [J].
DREBORG, S ;
FREW, A .
ALLERGY, 1993, 48 (14) :49-82
[6]  
Escudero A I, 1993, Allergol Immunopathol (Madr), V21, P153
[7]  
HILLIER K, 1980, Drugs of the Future, V5, P123
[8]  
HORAK F, 1987, WIEN KLIN WOCHENSCHR, V99, P509
[9]  
HORAK F, 1994, ZENTRALBLATT HNO, V144, P768
[10]  
JAGER S, 1988, ALLERGY, V43, P56